Atrys Health Company Description

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America.

It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests.

It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services.

The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016.

Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Atrys Health, S.A.

Country	Spain
Founded	2007
Industry	Biotechnology
Sector	Healthcare
Employees	2,061
CEO	Isabel Lozano Fernandez

Contact Details

Address: Príncipe de Vergara 132 Madrid, 28002 Spain
Phone	34 917 819 465
Website	atryshealth.com

Stock Details

Ticker Symbol	ATRY
Exchange	Madrid Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	ES0105148003
SIC Code	8071

Key Executives

Name	Position
Santiago De Torres Sanahuja	Executive Chairman
Dr. Carlos Cordon-Cardo	Founder and Scientific Vice President
Dr. Zvi Fuchs	Founder and Medical Vice President
Jose Maria Huch Ginesta	Chief Financial Officer
Luis Duran	Global Chief Technology Officer
Encarna Vega	Administration Director
Maria Marin	Head of Investor Relations
Gabriela Camunas	General Counsel
Pedro Salord	People Director
Rosa Urrutia	Head of Quality and Environment